Celgene Associate Director, Global Market Insights in Summit, New Jersey
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
Working closely with Celgene`s CAR-T Global Disease Team (Global Marketing leaders, clinical research and development, project leadership, manufacturing and translational) this role will be responsible for translating Business Intelligence (BI) and Market Research (MR) information into insights that inform the global long-term franchise strategies as well as global brand strategies preparing for market entry.
The responsibility of this role covers all critical areas of strategy informing insights based on cellular immuno-therapy, disease and business environment understanding from early pipeline through to market entry & brand growth in close collaboration with the Global Commercial Lead.
Responsibilities will include, but are not limited to:
Deliver competitor insights that inform global market entry scenario planning, global brand growth initiatives and the development of global brand lifecycle strategies and the global CAR T commercial operating model.
Based on identified strategic questions continuously monitor the competitive environment and emerging scientific data to identify market events with potential impact on our franchise and brand strategies (through congress coverage and key business intelligence projects)
Translate results into clear, concise and compelling implications for the team. Present, as needed, across functions and levels within the organization.
Closely collaborate with other global and regional Knowledge Services, Medical Information, Investor Relations, Public Relations, Market Insights colleagues and partner companies to integrate critical information into validated assumptions for global strategy building and forecasting.
Ensure existing data in-house is made available and fully leveraged to answer strategic questions
Utilize unique methodologies as appropriate
Conduct all projects within budget assigned, in a timely fashion, making tradeoffs as necessary
Skills/Knowledge and Experience Required:
BS/BA required; PHD or MBA or advanced degree preferred. 5+ years MR, BI, and/or consulting experience in the pharmaceutical/biotechnology industry required.
Experience in hematology strongly preferred.
Solid business understanding of pharmaceutical drug commercialization pathways
Solid knowledge of BI methodologies, techniques and tools preferred
Ability to discern critical market developments from large volumes of news, information, and/or data and communicate synthesized insights in a timely manner to key stakeholders
Ability to collaborate, manage expectations, and build consensus with colleagues in various geographies, roles, hierarchic levels etc
Experience in delivering concise, clear presentations to a variety of internal colleagues (including senior executives)
Demonstrated initiative, creativity, strategic capabilities, and ability to work effectively in complex, rapidly changing environments
Proven ability to drive business decisions as the Market Insight representative of a core team
Demonstrate and live Celgene Values through passion for the patient, courage to face our challenges and the unknown, trust in our words and our actions and excellence in delivering exceptional results
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.